Table 4: Adverse drug reactions attributed to intravenous mistletoe therapy.

System Organ ClassPreferred termTotal patientsTotal eventsIncidence (%)

Gastrointestinal disordersHypoaesthesia oral110.2
Vomiting110.2
Gastrointestinal disorders total220.2
General disorders and administration site conditionsPyrexia8101.7
Chills110.2
Fatigue110.2
Infusion site inflammation110.2
Local reaction220.4
General disorders and administration site conditions total10152.1
Immune system disordersHypersensitivity120.2
Immune system disorders total120.2
Musculoskeletal and connective tissue disordersMyalgia110.2
Musculoskeletal and connective tissue disorders total110.2
Nervous system disordersHeadache110.2
Paraesthesia110.2
Nervous system disorders total220.2
Skin and subcutaneous tissue disordersPruritus661.3
Rash110.2
Urticaria330.6
Skin and subcutaneous tissue disorders total10102.1

Total22324.6